Sfoglia per Autore
K252a inhibits the oncogenic properties of Met, the HGF receptor
2000-01-01 Alessandro Morotti; Carola Ponzetto
K252a inhibits the oncogenic proprerties of Met, the HGF receptor
2000-01-01 A.Morotti; A. Bosia; C. Ponzetto
Activation of NF-kB is essential for HGF-mediated tubuligenesis, but not for protection from apoptosis
2001-01-01 Muller M; Morotti A; Ponzetto C
Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis.
2002-01-01 MULLER M.; MOROTTI A.; C. PONZETTO
Wilms’ tumour gene (WT1) is modulated by NF-kB transcriptional factor
2002-01-01 Messa F; Cilloni D; Fava M; Morotti A; Messa E; Gottardi E; Saglio G
NF-KB inhibitors are new approaches in the molecular therapy of leukemias
2002-01-01 Morotti A.; Cilloni D.; Pautasso M.; Messa F.; Gottardi E.; Saglio G
New perspectives for molecular targeted therapy in human leukemias
2002-01-01 G.Saglio; D;Cilloni; A. Morotti; C. Pilatrino; G. Volpe; E. Gottardi; P. Scaravaglio; E.Giugliano; E. Messa; G. Rege-Cambrin; A. Guerrasio
NF-kB is involved in the modulation of the Wilms tumor gene
2002-01-01 Messa F.; Cilloni D.; Morotti A; Messa E; Fava M; Gottardi E; Saglio G
The quantitaive assessment of WT1 gene expression as a method to predict response to STI571 therapy in CML patients
2002-01-01 Cilloni D.; Messa F.; Gottardi E.; Morotti A.; Giugliano E.; Messa E.; Rege-Cambrin G.; Pane F.; Martinelli M.; Baccarani M.; Saglio G
Signaling through Bcr/Abl
2002-01-01 Alessandro Morotti; Giuseppe Saglio
K252a inhibits the oncogenic properties of Met, the HGF receptor.
2002-01-01 A. MOROTTI; S. MILA; P. ACCORNERO; E. TAGLIABUE; C. PONZETTO
Resveratrol and Valproate induce differentiation of AML blasts through NF-kB inhibition
2003-01-01 Morotti A; Pautasso M; Cilloni D; Messa F; Baraban D; Gottardi E; Saglio G
Sodium valproate enhances Imatinib induced apoptosis and growth arrest in Bcr-Abl cell lines
2003-01-01 Morotti A.; Cilloni D.; Messa F.; Pautasso M.; Rege-Cambrin G.; Pilatrino C.; Guerrasio A.; Gottardi E.; Alberti D; Saglio G
The IKK inhibitor PS1145 allows to overcome Imatinib resistance
2004-01-01 Cilloni D; Messa F; Arruga F; Defilippi I; Morotti A; Messa E; Carturan S; Fava M; Gottardi E; Martinelli G; Baccarani M; Saglio G
SODIUM VALPROATE ENHANCES IMATINIB INDUCED APOPTOSIS AND GROWTH ARREST IN BCR-ABL CELL LINES
2004-01-01 Morotti A; Cilloni D; Pautasso M; Baraban D; Messa F; Arruga F; De Filippi I; Messa E; Carturan S; Rege-cambrin G; Pilatrino C; Guerrasio A; Gottardi E; Saglio G
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia
2004-01-01 SAGLIO G; MOROTTI A; MATTIOLI G; MESSA E; GIUGLIANO E; VOLPE G; REGE-CAMBRIN; G; CILLONI D.
Over-Expression of the P65 Subunit of NF-kB and Increased DNA Binding Activity of NF-kB Is a Common Event Both in Philadelphia Positive and Negative Chronic Myeloproliferative Disorders.
2004-01-01 Alessandro Morotti; Veronica Ullmannova; Daniela Cilloni; Francesca Messa; Manuela Messa; Ilaria Defilippi; Francesca Arruga; Sonia Carturan; Cedrik Haskovec; Enrico Gottardi; Giuseppe Saglio
MODULATION OF APOPTOSIS
2004-01-01 Saglio G; Morotti A; Cilloni D
Over-expression of the p65 subunit of NF-kB and increased NF-kB binding activity is a common event both in Philadelphia positive and negative Chronic Myeloproliferative Disorders
2004-01-01 Morotti A; Ullmannova V; Cilloni D; Messa F; Messa E; Defilippi I; Arruga F; Carturan S; Haskovec C; Gottardi E; Saglio G
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation
2004-01-01 CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GIUGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M; SAGLIO G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| K252a inhibits the oncogenic properties of Met, the HGF receptor | 2000 | Alessandro Morotti; Carola Ponzetto | |
| K252a inhibits the oncogenic proprerties of Met, the HGF receptor | 2000 | A.Morotti; A. Bosia; C. Ponzetto | |
| Activation of NF-kB is essential for HGF-mediated tubuligenesis, but not for protection from apoptosis | 2001 | Muller M; Morotti A; Ponzetto C | |
| Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. | 2002 | MULLER M.; MOROTTI A.; C. PONZETTO | |
| Wilms’ tumour gene (WT1) is modulated by NF-kB transcriptional factor | 2002 | Messa F; Cilloni D; Fava M; Morotti A; Messa E; Gottardi E; Saglio G | |
| NF-KB inhibitors are new approaches in the molecular therapy of leukemias | 2002 | Morotti A.; Cilloni D.; Pautasso M.; Messa F.; Gottardi E.; Saglio G | |
| New perspectives for molecular targeted therapy in human leukemias | 2002 | G.Saglio; D;Cilloni; A. Morotti; C. Pilatrino; G. Volpe; E. Gottardi; P. Scaravaglio; E.Giugliano; E. Messa; G. Rege-Cambrin; A. Guerrasio | |
| NF-kB is involved in the modulation of the Wilms tumor gene | 2002 | Messa F.; Cilloni D.; Morotti A; Messa E; Fava M; Gottardi E; Saglio G | |
| The quantitaive assessment of WT1 gene expression as a method to predict response to STI571 therapy in CML patients | 2002 | Cilloni D.; Messa F.; Gottardi E.; Morotti A.; Giugliano E.; Messa E.; Rege-Cambrin G.; Pane F.; Martinelli M.; Baccarani M.; Saglio G | |
| Signaling through Bcr/Abl | 2002 | Alessandro Morotti; Giuseppe Saglio | |
| K252a inhibits the oncogenic properties of Met, the HGF receptor. | 2002 | A. MOROTTI; S. MILA; P. ACCORNERO; E. TAGLIABUE; C. PONZETTO | |
| Resveratrol and Valproate induce differentiation of AML blasts through NF-kB inhibition | 2003 | Morotti A; Pautasso M; Cilloni D; Messa F; Baraban D; Gottardi E; Saglio G | |
| Sodium valproate enhances Imatinib induced apoptosis and growth arrest in Bcr-Abl cell lines | 2003 | Morotti A.; Cilloni D.; Messa F.; Pautasso M.; Rege-Cambrin G.; Pilatrino C.; Guerrasio A.; Gottardi E.; Alberti D; Saglio G | |
| The IKK inhibitor PS1145 allows to overcome Imatinib resistance | 2004 | Cilloni D; Messa F; Arruga F; Defilippi I; Morotti A; Messa E; Carturan S; Fava M; Gottardi E; Martinelli G; Baccarani M; Saglio G | |
| SODIUM VALPROATE ENHANCES IMATINIB INDUCED APOPTOSIS AND GROWTH ARREST IN BCR-ABL CELL LINES | 2004 | Morotti A; Cilloni D; Pautasso M; Baraban D; Messa F; Arruga F; De Filippi I; Messa E; Carturan S; Rege-cambrin G; Pilatrino C; Guerrasio A; Gottardi E; Saglio G | |
| Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia | 2004 | SAGLIO G; MOROTTI A; MATTIOLI G; MESSA E; GIUGLIANO E; VOLPE G; REGE-CAMBRIN; G; CILLONI D. | |
| Over-Expression of the P65 Subunit of NF-kB and Increased DNA Binding Activity of NF-kB Is a Common Event Both in Philadelphia Positive and Negative Chronic Myeloproliferative Disorders. | 2004 | Alessandro Morotti; Veronica Ullmannova; Daniela Cilloni; Francesca Messa; Manuela Messa; Ilaria Defilippi; Francesca Arruga; Sonia Carturan; Cedrik Haskovec; Enrico Gottardi; Giuseppe Saglio | |
| MODULATION OF APOPTOSIS | 2004 | Saglio G; Morotti A; Cilloni D | |
| Over-expression of the p65 subunit of NF-kB and increased NF-kB binding activity is a common event both in Philadelphia positive and negative Chronic Myeloproliferative Disorders | 2004 | Morotti A; Ullmannova V; Cilloni D; Messa F; Messa E; Defilippi I; Arruga F; Carturan S; Haskovec C; Gottardi E; Saglio G | |
| Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation | 2004 | CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GIUGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M; SAGLIO G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile